sharecast

{{ storiesRelated.title }}

News And Announcements
04 Sep
cbcitylondon
Numis beats out JP Morgan as City's stockbroker of choice

JP Morgan Cazenove had lost its long-held standing as London's most popular corporate stockbroker to rival Numis Securities in the latest corporate advisers ranking guide.

04 Sep
cbharvey
Ashtead may see USD50m of storm disaster recovery spending and more - Jefferies

Assessing the impact of Hurricane Harvey on Ashtead Group's US-based Sunbelt is difficult, said Jefferies, but the arm could benefit from a sizeable amount of disaster recovery revenue based on previous disasters.

04 Sep
billetes euros
Sirius Real Estate completes one disposal, two acquisitions

Branded business park operator Sirius Real Estate updated the market on Monday, on the completion of a €7m disposal of a “mature asset”, as well as two property acquisitions for €25. 8m and its entry into the FTSE AllShare and SmallCap indices.

04 Sep
libra, esterlina, divisa, moneda, reino unido pound currency
Malvern International pens deal with Oxford University Press

Educational services provider Malvern International announced that its wholly-owned UK subsidiary, Malvern House International, had entered into an agreement with Oxford University Press to allow for the use of OUP's content and expertise in relation to developing mobile application games for the learning of English.

04 Sep
Finance, graph
Midatech submits clinical trial application for MTD201

International speciality pharmaceutical company Midatech Pharma announced the submission of a clinical trial application for a first in human study of its MTD201 programme in carcinoid cancer and acromegaly.

04 Sep
Astrazeneca
Faron's 'Traumakine' set for swift progress through FDA process

Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that the FDA had proposed that the company could proceed directly to Biologics License Application (BLA) submission, pending positive results from the two ongoing Phase III trials with the company's wholly-owned product, ‘Traumakine’, for the treatment of acute respiratory distress syndrome (ARDS).

04 Sep
calculatrice et trombones comptes entrepreneurs entreprises argent finances tpe pme entreprenariat finances banques startup business plan argent
Plutus PowerGen signs heads of terms with JCB Power Products

Flexible energy generation company Plutus PowerGen has signed a heads of terms with JCB Power Products Broadcrown Limited, it announced on Monday, to design, procure and supply the required generators for the company's UK ‘FlexGen’ projects.

04 Sep
cash money sterling pound
Science Group to acquire Technology Sciences Group

Science Group announced on Monday that it has exchanged contracts to acquire 100% of the equity of Technology Sciences Group, Technology Sciences Europe and associated subsidiaries from Dentons Innovation Group US.

04 Sep
handshake
Novartis CEO Jimenez to step down

Swiss pharmaceuticals company Novartis said on Monday that chief executive officer Joseph Jimenez plans to step down next year after eight years in the role.

04 Sep
Money coins pound
Icewine testing recommences, says 88 Energy

Energy investment company 88 Energy updated the market on Project Icewine, located onshore North Slope of Alaska, on Monday, confirming that the Icewine#2 well was shut-in on 10 July to allow for imbibition and pressure buildup to occur within the HRZ shale.

04 Sep
Cerveza brindis
C&C picks up 47% stake in pubco Admiral Taverns

C&C Group, producers of Magners cider, announced on Monday that it had reached an agreement, along with US investors Proprium Capital Partners, to acquire Admiral Taverns.

04 Sep
Money cash dollars
SimiGon awarded 'prime contract' with Federal Aviation Administration

Modelling, simulation and training solutions provider SimiGon announced on Monday that it has been awarded a “prime contract” with the US Federal Aviation Administration, to deliver the ‘SIMbox’ simulation development tools and training in support of the regulator’s advanced unmanned aircraft systems (UAS) research simulator.

04 Sep
biopharma-laboratoire-recherche-medicale
Bioventix share price spikes after trading update

Clinical antibody specialist Bioventix expects revenues and pre-tax profits to be ahead of market projections for the year after its revenue increased by almost a quarter.

04 Sep
Internet
Kainos Group announces 'solid performance' ahead of interim report

Digital services and platforms provider, Kainos Group said on Monday its full-year results were expected to be in line with current market expectations.

04 Sep
cash money sterling pay deal offer acquisition m&a
Charles Taylor to buy US insurance administrator MRM

Charles Taylor subsidiary, Charles Taylor General Agency, has agreed to buy US West Coat insurance claims third party administrator Metro Risk Management for up to $1. 8m.

04 Sep
edgar test 10
NetScientific's ProAxsis gets CE mark for NEATstik

Transatlantic healthcare intellectual property commercialisation group NetScientific updated the market on progress at its portfolio company ProAxsis on Monday.

04 Sep
Money cash dollars
Kromek awarded five-year contract for x-ray technology

Radiation detection technology company Kromek announced on Monday that it has been awarded a five-year contract, worth $2. 0m over the period, by an unnamed new OEM customer which it described as a “leading company” in x-ray imaging systems.

04 Sep
victrex, plastics
Victrex says effective tax rate to drop to 12%, EPS benefit seen

Victrex said on Monday that the group's effective tax rate under Patent Box - which enables companies to apply a lower rate of corporation tax to profits earned after 1 April 2013 to its patented inventions - is expected to drop.

04 Sep
handshake
Johnson Service sees FY ahead of market views, CEO to step down

Johnson Service said on Monday that it expects its full-year results to be slightly ahead of current market views as it announced the resignation of chief executive officer Chris Sander after 33 years at the company.

04 Sep
Astrazeneca
Angle upbeat on new research from Duesseldorf

Liquid biopsy company Angle announced the publication of research by Heinrich Heine University of Duesseldorf on Monday, which reportedly demonstrated the measurement of key proteins in breast cancer using Parsortix, which may advise therapy decisions in breast cancer treatment.